Record overview
Status and phase
Status: UNKNOWN
Phase: PHASE2
Sponsor: Russian Academy of Medical Sciences
Condition: Triple Negative Breast Cancer
NCT02685657
Neoadjuvant Chemotherapy Docetaxel With or Without SELUMETINIB in Patients With Triple Negative Breast Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Unknown Status Signal
Timeline signals: stale_update_signal | primary_completion_date_past_signal
Results signal: Low Signal
Operational burden: few_sites_large_trial_signal
Stopped reason
Context when available
No stop reason available in the current public record.